Clinical trial
Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis
NCT03461419 is registered in ClinicalTrials.gov with Healeon Medical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis
- Lead sponsor
- Healeon Medical Inc
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- August 1, 2019
- Completion date
- December 15, 2028
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune, multiple sclerosis